Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01120704 · ClinicalTrials.gov registry record · Phase 4
Evaluation of Treatments to Improve Smoking Cessation Medication Adherence
A Phase 4 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 4
- Development phase
- 544
- Enrollment target
NCT01120704: Completed Phase 4 study, sponsored by University of Wisconsin, Madison.
NCT01120704 is a Phase 4 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 544 participants, roughly in line with the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01120704, a Phase 4 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 544 participants
- Enrollment target
Study Summary
Many smokers fail to take their smoking cessation medication as recommended. This research is designed to identify treatments that improve the use of cessation medications and to determine whether an increase in medication use results in increased cessation success. This research will also identify treatments that help people stay quit after a quit attempt and will pioneer more efficient research methods.
Primary Outcome
Self-Reported 7-Day Point-Prevalence Abstinence is a dichotomous outcome with values of 0 and 1 where 0=smoking on one or more of the past 7 days at the assessment endpoint (52 weeks post-quit) and 1=no smoking on any of the past 7 days at the assessment endpoint (i.e., abstinent for the past 7 days); this outcome will be analyzed in a logistic regression analysis model. Note: This abstinence primary outcome replaces latency to relapse (now designated as a secondary outcome) because reviewers o
Interventions
- DRUG Short Term Combination Nicotine Replacement Therapy (patch + gum)
- DRUG Long Term Combination Nicotine Replacement Therapy (patch + gum)
- BEHAVIORAL Intensive Maintenance Counseling
- BEHAVIORAL Cognitive Medication Adherence Counseling (CAM)
- BEHAVIORAL Electronic Medication Monitoring Device (the Helping Hand) + Feedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 544 participants |
| Start Date | 2010-06 |
| Est. Completion | 2014-05 |
| Phase | Phase 4 |
What the finished NCT01120704 record still lists
NCT01120704 is an interventional study that assigns participants to a tested intervention. The registered 544 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target.
The record links to 0 conditions, and to 5 interventions - of which Short Term Combination Nicotine Replacement Therapy (patch + gum) is the first listed.
NCT01120704 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01120704 about?
NCT01120704 is a clinical study titled "Evaluation of Treatments to Improve Smoking Cessation Medication Adherence". Many smokers fail to take their smoking cessation medication as recommended. This research is designed to identify treatments that improve the use of cessation medications and to determine whether an increase in medication use results in increased cessation success. This research will also identify ...
What is the current status of trial NCT01120704?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 544 participants. The study started on 2010-06. Estimated completion is 2014-05.
What interventions are being tested in trial NCT01120704?
The interventions under investigation include: Short Term Combination Nicotine Replacement Therapy (patch + gum) (DRUG), Long Term Combination Nicotine Replacement Therapy (patch + gum) (DRUG), Intensive Maintenance Counseling (BEHAVIORAL), Cognitive Medication Adherence Counseling (CAM) (BEHAVIORAL), Electronic Medication Monitoring Device (the Helping Hand) + Feedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT01120704?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01120704's enrollment target sits among peer trials
544 156th of 2000 higher than 1,844 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03127761 · 544 participants
Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma
- NCT04378790 · 544 participants · Phase 3
A Randomized Trial to Evaluate Sequential vs Simultaneous Patching
- NCT06118502 · 544 participants · NA
A Clinical Trial of Adaptive Treatment for Early Smoking Cessation Relapse
- NCT06170437 · 544 participants · NA
Smoke-free Home Study in Subsidized Housing
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia